Photo of Vladimir Bogdanov

Vladimir Bogdanov

  • ADJUNCT ASSISTANT PROFESSOR Medicine, Hematology and Medical Oncology
Print ProfilePrint Profile


  • Ph.D., Mount Sinai School of Medicine

  • Mount Sinai School of Medicine



New topic

Dr. Bogdanov studies the biology of Tissue Factor ((TF), also known as CD142, tissue thromboplastin, or coagulation factor III), a molecule essential for blood coagulation. Some of his earlier work showed that a previously unknown, naturally occurring molecule - an alternatively spliced soluble circulating TF isoform, termed asTF - is likely to be involved in thrombus formation. Importantly, recombinant asTF exhibits functional activity in the presence of phospholipids, and native asTF co-localizes with platelet aggregates.

In collaboration with Mark B. Taubman (U. Rochester), Dr. Bogdanov recently identified and characterized an analogous alternatively spliced TF molecule that exists in the mouse. Dr. Bogdanov is currently elucidating molecular pathways governing TF pre-mRNA processing. In clinical studies, he is working with collaborators at Mount Sinai's Cardiovascular Institute to qualitatively assess the levels of circulating plasma TF activity in patients undergoing interventional treatment for CVD.


Tardos JG, Eisenreich A, Deikus G, Bechhofer DH, Chandradas S, Zafar U, Rauch U, Bogdanov VY. SR proteins ASF/SF2 and SRp55 participate in tissue factor biosynthesis in human monocytic cells. J Thromb Haemost 2008 May; 6(5): 877-884.

Bogdanov VY. Blood coagulation and alternative pre-mRNA splicing: an overview. Curr Mol Med 2006 Dec; 6(8): 859-869.

Bogdanov VY, Kirk RI, Miller C, Hathcock JJ, Vele S, Gazdoiu M, Nemerson Y, Taubman MB. Identification and characterization of murine alternatively spliced tissue factor. J Thromb Haemost 2006 Jan; 4(1): 158-167.

Szotowski B, Goldin-Lang P, Antoniak S, Bogdanov VY, Pathirana D, Pauschinger M, Dorner A, Kuehl U, Coupland S, Nemerson Y, Hummel M, Poller W, Hetzer R, Schultheiss HP, Rauch U. Alterations in myocardial tissue factor expression and cellular localization in dilated cardiomyopathy. J Am Coll Cardiol 2005 Apr 5; 45(7): 1081-1089.

Bogdanov VY, Balasubramanian V, Hathcock J, Vele O, Lieb M, Nemerson Y. Alternatively spliced human tissue factor: a circulating, soluble, thrombogenic protein. Nat Med 2003 Apr; 9(4): 458-462.

Schecter A, Spirn B, Rossikhina M, Giesen PL, Bogdanov VY, Fallon J, Fisher E, Schnapp LM, Nemerson Y, Taubman M. Release of active tissue factor by human arterial smooth muscle cells. Circ Res 2000 Jul 21; 87(2): 81-2.

Industry Relationships

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Dr.Bogdanov is not currently required to report Industry relationships.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.

Edit profile in Sinai Central


Annenberg Building Floor 23rd Floor Room Room 23-64
1468 Madison Avenue
New York, NY 10029

Tel: 212-241-0579